文献速递鼻科

鼻后神经射频神经毁损术:系统综述与荟萃分析

Radiofrequency Neurolysis of the Posterior Nasal Nerve: A Systematic Review and Meta-Analysis.
PubMed 文献 · Laryngoscope · 2023-07-29

该系统综述与荟萃分析检索多个数据库,纳入5项研究(4项进入荟萃分析),共284例接受鼻后神经温控射频神经毁损术的慢性鼻炎患者。3个月时rTNSS较基线合并变化为-4.28(95%CI -5.10至-3.46),3个月和6个月应答率分别为77.11%和80.80%,21例(7.4%)患者报告36例不良事件,结论提示该治疗有效且安全性总体良好。

要点

  • 3个月rTNSS较基线合并变化为-4.28(95%CI -5.10至-3.46)。
  • 3个月应答率为77.11%,6个月应答率为80.80%。
  • 21例(7.4%)患者共报告36例不良事件。

核心结论

  • 本综述结果提示,鼻后神经温控射频神经毁损术对治疗慢性鼻炎症状有效,且总体安全性良好。

研究设计与样本

  • 系统检索Pubmed/Medline、Embase、Scopus、Web of Science,检索于2023年4月进行,对发表年份无限制。
  • 纳入以射频神经毁损术作为单一手术方式治疗慢性鼻炎患者、报告反射性总鼻症状评分(rTNSS)结局的随机对照试验(RCT)和前瞻性研究。
  • 系统综述纳入5项研究,其中4项纳入荟萃分析,共284例参与者接受治疗。

主要发现

  • 3个月时rTNSS评分较基线的合并变化为-4.28(95%CI,-5.10至-3.46)。
  • 3个月合并应答率(基线rTNSS降低≥30%)为77.11%(95%CI,68.21%-86.01%),6个月为80.80%(95%CI,70.85%-90.76%)。
  • 随访时鼻后滴漏评分、咳嗽评分及生活质量(QoL)也显著改善。
  • 21例(7.4%)患者共报告36例不良事件。

关键数值与推荐

  • 应答定义为基线rTNSS降低≥30%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Temperature-controlled radiofrequency neurolysis of the posterior nasal nerve (PNN) has been approved for use since 2020. This review synthesized the published data to assess its efficacy for treatment of chronic rhinitis. DATA SOURCES: Pubmed/Medline, Embase, Scopus, Web of Science. REVIEW METHODS: A systematic search was conducted with no restrictions on publication years in April 2023. RCTs and prospective investigations that reported the reflective Total Nasal Symptom Score (rTNSS) outcome of radiofrequency neurolysis as a single procedure in chronic rhinitis patients were included. Pooled estimates for change in rTNSS from baseline at 3 months and responder rates (≥30% reduction in baseline rTNSS) at 3 and 6 months were obtained. Other outcomes, such as postnasal drip and cough scores, quality of life (QoL) measures, and adverse events were included for qualitative review. RESULTS: Five studies were included in the systematic review, of which four were included in the meta-analysis. A total of 284 participants underwent treatment. The pooled change in rTNSS score at 3 months was -4.28 (95% CI, -5.10 to -3.46). The pooled responder rate at 3 months was 77.11% (95% CI, 68.21%-86.01%) and at 6 months 80.80% (95% CI, 70.85%-90.76%). Postnasal drip and cough scores and QoL also improved significantly at follow up. A total of 36 adverse events were reported in 21 (7.4%) patients. CONCLUSIONS: The findings from this review suggest that temperature-controlled radiofrequency neurolysis of the PNN is effective at treating chronic rhinitis symptoms and that it has an overall favorable safety profile. Laryngoscope, 134:507-516, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Yu AJ, Tam B, Wrobel B, et al. Radiofrequency Neurolysis of the Posterior Nasal Nerve: A Systematic Review and Meta-Analysis. Laryngoscope. 2023. PMID: 37515507. doi:10.1002/lary.30911

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。